Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia*
Authors:
- Emili DiazEDEmili Diaz
- Emma MuñozEMEmma Muñoz
- Thiago LisboaTLThiago Lisboa
- Frederic GomezFrederic Gomez
- Pieter O. DepuydtPDPieter O. Depuydt
- Stijn I. BlotSBStijn I. Blot
- Jordi RelloJRJordi Rello
- 1 September 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 35 (9) , 2064-2070
Abstract
To assess whether bacteremic ventilator-associated pneumonia (B-VAP) differs in terms of risk factors, organisms, and outcomes from nonbacteremic VAP (NB-VAP). A retrospective, single-center, observational, cohort study. Multidisciplinary teaching intensive care unit. Adult patients requiring mechanical ventilation, identified as having VAP in a 44-month prospective surveillance database. Each B-VAP patient was matched with two controls with VAP and negative blood cultures based on the microbial etiology responsible for VAP, Acute Physiology and Chronic Health Evaluation II score on admission (±3 points), diagnostic category, and length of stay before pneumonia onset. B-VAP was documented in 35 (17.6%) of 199 microbiologically confirmed VAP episodes. B-VAP developed later (median 8 vs. 5 days, p = .03) and was more frequent in previously hospitalized patients (34.3% vs. 11.0%, p < .01) and in older patients (57.4 ± 15.2 vs. 49.5 ± 19.3 yrs, p = .02). B-VAP was more often caused by methicillin-resistant Staphylococcus aureus (12 [20.7%] vs. 13 [5.1%] episodes, p < .01), whereas Haemophilus influenzae was associated with NB-VAP (52 [20.4%] vs. 0, p < .01). Multivariate analysis confirmed an association between B-VAP and both methicillin-resistant S. aureus (odds ratio 3.18; 95% confidence interval 1.15–8.76, p < .01) and prior hospitalization (odds ratio 2.56; 95% confidence interval 1.01–6.54, p = .05). After adjustment for potential confounders, B-VAP (hazard ratio for death 2.55; 95% confidence interval 1.25–5.23, p = .01) and vasopressor use (hazard ratio 2.43; 95% confidence interval 1.23–4.82, p = .01) remained associated with mortality. The estimated relative risk of death for bacteremic cases was 2.86 (95% confidence interval 1.09–7.51), since mortality for cases and matched NB-VAP controls was 40.6% (13 of 32) and 19.3% (11 of 57), respectively. B-VAP occurs later during intensive care unit stay, is more frequent in previously hospitalized patients, is more often caused by methicillin-resistant S. aureus, and is independently associated with increased intensive care unit mortality.Keywords
This publication has 37 references indexed in Scilit:
- Epidemiology, Treatment, and Outcomes of Nosocomial Bacteremic Staphylococcus aureus PneumoniaChest, 2005
- Staphylococcus aureus bacteremic pneumonia: differences between community and nosocomial acquisitionInternational Journal of Infectious Diseases, 2003
- Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: A prospective case-control studyCritical Care Medicine, 2001
- Blood Cultures Have Limited Value in Predicting Severity of Illness and as a Diagnostic Tool in Ventilator-Associated PneumoniaChest, 1999
- Nosocomial infections in medical intensive care units in the United StatesCritical Care Medicine, 1999
- The Attributable Morbidity and Mortality of Ventilator-Associated Pneumonia in the Critically Ill PatientAmerican Journal of Respiratory and Critical Care Medicine, 1999
- The Value of Routine Microbial Investigation in Ventilator-Associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 1997
- The Prevalence of Nosocomial Infection in Intensive Care Units in EuropeJAMA, 1995
- Incidence, Etiology, and Outcome of Nosocomial Pneumonia in Mechanically Ventilated PatientsChest, 1991
- Incidence and etiology of pneumonia acquired during mechanical ventilationCritical Care Medicine, 1989